F. F. Fleming et al. / Tetrahedron 59 (2003) 5585–5593
5591
procedure with a THF solution (5 mL) of 4a (16 mg) and
2
EtOAc/hexanes), 41.1 mg (72%) of 7p as an oil: IR (Film)
2
21 1
PhS(CH ) MgCl provided, after purification by radial
2
3414, 2217, 1603 cm ; H NMR d 1.09 (d, J¼6.7 Hz, 3H),
1.15 (d, J¼7.1 Hz, 3H), 2.64 (s, 1H), 3.13–3.22 (m, 1H), 3.45
(s, 1H), 4.30(ABq, Dn¼31.5 Hz, J¼12.3 Hz, 2H), 5.79 (s, 1H),
3
chromatography (3:7 EtOAc/hexanes), 19.3 mg (42%) of 7k
and 20 mg (53%) of 7l as an oils. For 7k IR (film) 3426,
2
1
1
13
3
1
060, 2219, 1632, 1584 cm ; H NMR d 1.60 (br s, 1H),
.78–1.88 (m, 2H), 2.51 (dd, J¼8 Hz, 2H), 2.95 (t,
7.32–7.45 (m, 5H); C NMR d 20.2, 20.3, 35.2, 57.0, 70.0,
116.5, 117.0 126.0, 128.7, 140.1, 163.4 MS m/e 231 (M2H).
J¼7.3 Hz, 2H), 4.20 (s, 2H), 5.57 (s, 1H), 7.17–7.60 (m,
1
3
5
1
2
(
1
H); C NMR d 27.6, 31.0, 33.5, 64.0, 94.6, 126.4, 129.0,
29.8, 165.7; MS e/m 233. For 7l IR (film) 3438, 3058,
216, 1579 cm2 ; H NMR d 2.03 (s, 1H), 4.07 (s, 2H), 5.81
3.3.3. (2Z)-3-(Hydroxymethyl)-2-(1-hydroxy-3-phenyl-
propyl)-4-methylpent-2-enenitrile (7q). Performing the
general conjugate addition–alkylation procedure with a
THF solution (5 mL) of 4a (12 mg), i-PrMgCl and
3-phenylpropanal provided, after purification by radial
chromatography (3:7 EtOAc/hexanes), 24.9 mg (65%) of
1 1
1
3
s, 1H), 7.27- 7.55 (m, 5H); C NMR d 64.1, 93.6, 127.9,
þ
29.9, 134.7, 162; MS m/e 191 (M ).
7q as an oil: IR (film) 3410, 2214, 1603 cm2 ; H NMR d
1.07 (d, J¼6.4 Hz, 3H), 1.15 (d, J¼6.3 Hz, 3H), 1.70 (br s,
1H), 1.97–2.21 (m, 2H), 2.32 (br s, 1H), 2.74 (t, J¼7.5 Hz,
2H), 3.14–3.23 (m, 1H), 4.14 (s, 2H), 4.55 (t, J¼6.8 Hz, 1H),
1 1
3
2
.2.12. (2Z)-3-(Hydroxymethyl)-5,5-dimethyl-5-silahex-
-enenitrile (7m) and (2E)-1-[1-(2,2-dimethyl-2-sila-
propyl)-2-hydroxyethylidene]-2-(hydroxymethyl)prop-
-ene-1,3-dicarbonitrile (7n). Performing the general
conjugate addition procedure with a THF solution (5 mL)
2
1
3
7.12–7.31 (m, 5H); C NMR d 20.2, 20.4, 31.8, 35.1, 36.8,
of 4a (20 mg) and (CH ) SiCH MgCl provided, after
3
57.0, 67.4, 116.3, 117.1, 126.2, 128.4, 128.5, 140.8, 164.3.
3
2
purification by radial chromatography (3:7 EtOAc/
hexanes), 16 mg (38.3%) of 7m and 14 mg (19.4) of 7n as
3.3.4. (2E)-4-Hydroxy-2-(1-hydroxy-3-phenylpropyl)-3-
phenylbut-2-enenitrile (7r). Performing the general con-
jugate addition–alkylation procedure with a THF solution
(5 mL) of 4a (15 mg), PhMgCl and 3-phenylpropanal
provided, after purification by radial chromatography (3:7
EtOAc/hexanes), 30.9 mg (57%) of 7r as an oil. IR (film)
1
an oils. For 7m: IR (Film) 3456, 2215, 1620; H NMR d
1
3
0
NMR d 21.0, 24.6, 65.3, 89.2, 118.1, 166.7; MS m/e 169.
.12 (s, 9H), 1.94 (s, 2H), 4.13 (s, 2H), 5.39 (s, 1H);
C
2
1 1
For 7n: IR (Film) 3456, 2221, 1630 cm ; H NMR d 0.22
s, 9H), 2.38 (s, 2H), 4.27 (s, 2H), 4.36 (s, 2H), 5.84 (s, 1H);
(
1
3
21
1
C NMR d-0.8, 28.0, 62.4, 63.3, 100.2, 100.6, 116.3, 157.1,
67.5; MS m/e 250 (MþH).
3386, 2216, 1602 cm ; H NMR d 2.1–2.24 (m, 2H),
2.74–2.78 (m, 2H), 3.20 (brs, 2H), 4.39 (AB , Dn¼40.0 Hz,
1
q
J¼13.4 Hz, 2H), 4.69 (t, J¼7 Hz, 1H), 7.20–7.38 (m, 10H);
1
3
3
.3. General conjugate addition–alkylation procedure
C NMR: 31.7, 37.1, 62.3, 67.6, 116.9, 118.2, 126.3, 127.8,
28.4, 128.6, 128.8, 129.6, 137.5, 140.6, 157.4.
1
A THF solution of t-BuMgCl (1.0 equiv., 1–2 M) was added
to a 2788C, THF solution of the g-hydroxyalkynenitrile
3.3.5. (2Z)-4-Hydroxy-2-(1-hydroxy-3-phenylpropyl)-4-
methyl-3-phenylpent-2-enenitrile (7s). Performing the
general conjugate addition–alkylation procedure with a
THF solution (5 mL) of 4c (17 mg), PhMgCl and 3-phenyl-
propanal provided, after purification by radial chromato-
graphy (3:7 EtOAc/hexanes), 28.5 mg (57%) of 7s as an oil;
(
1 equiv.) followed, after 5 min, by a THF solution of the
appropriate Grignard reagent (1.1 equiv., 1–3 M). After
5 min, the reaction mixture was allowed to warm to room
4
temperature (15 min), re-cooled to 2788C, and then a hexanes
solution of t-BuLi (1.2 equiv., 1.5 M) was added. The cooling
bath was then removed, and after 15 min neat aldehyde
IR (film) 3434, 2215, 1602 cm2 ; H NMR d 1.25 (s, 3H),
1 1
(
aqueous saturated NH Cl. The crude reaction mixture was
1.5 equiv.) was added, followed, after a further 30 min, by
1.36 (s, 3H), 1.40–1.60 (m, 2H), 2.01–2.27 (m, 2H), 2.72–
1
3
2.92 (s, 2H), 5.22–5.27 (m, 1H), 7.20–7.71 (m, 10H);
C
4
extracted with EtOAc, the combined extracts were passed
through a short plug of silica gel (2£1 cm column),
concentrated, and purified by radial chromatography.
NMR: 30.6, 31.4, 32.1, 37.2, 67.1, 74.9, 116.8, 120.1, 126.1,
127.1, 127.9, 128.5, 139.4, 141.2, 165.1; HRMS (ESI) calcd
þ
for (MþNa ) C H NO 344.1621, found 344.1611.
2
1
23
2
3.3.1. (2Z)-4-Hydroxy-2-(hydroxyphenylmethyl)-3-
phenylbut-2-enenitrile (7o). Performing the general con-
jugate addition–alkylation procedure with a THF solution
3.3.6. (2Z)-4-Hydroxy-2-(1-hydroxy-3-phenylpropyl)-
3,4-dimethylpent-2-enenitrile (7t). Performing the general
conjugate addition–alkylation procedure with a THF
solution (5 mL) of 4c (20 mg), MeMgCl and 3-phenyl-
propanal, provided after purification by radial chromato-
graphy (3:7 EtOAc/hexanes), 29 mg (61%) of 7t as an oil:
(
5 mL) of 4a (10 mg), PhMgCl and PhCHO provided, after
purification by radial chromatography (3:7 EtOAc/
hexanes), 19.6 mg (60%) of 7o as a light brown solid (mp
23–1258C): IR (film) 3388, 2219, 1595 cm2 ; H NMR d
1
1
IR (film) 3433, 2211, 1602 cm ; H NMR d 1.21–1.37 (m,
1H), 1.34 (s, 3H), 1.42 (s, 3H), 1.94–2.20 (m, 2H), 2.09 (s,
3H), 2.65–2.85 (m, 3H), 5.07–5.12 (m, 1H), 7.18–7.46 (m,
21 1
1
4
.55–4.57 (m, 2H), 5.40–5.42 (m, 1H, exchanges with
D O), 5.94–5.96 (m, 1H), 6.21 (d, J¼4.0 Hz, 1H,
2
1
3
13
exchanges with D O), 7.26–7.50 (m, 10H); C NMR d
2
5H); C NMR: 22.0, 29.7, 30.3, 32.0, 37.3, 66.8, 75.2,
116.5, 117.7, 125.9, 128.4 (doubled), 141.3, 161.8; MS m/e
259 (M2OH).
6
1
0.6, 67.6, 117.4, 118.2, 125.9, 127.3, 128.1, 138.5, 141.6,
56.0 MS m/e 247 (M2H O).
2
3
.3.2. (2Z)-3-(Hydroxymethyl)-2-(hydroxyphenyl-
methyl)-4-methylpent-2-enenitrile (7p). Performing the
general conjugate addition–alkylation procedure with a THF
solution (5 mL) of 4a (20 mg), i-PrMgCl and PhCHO
provided, after purification by radial chromatography (4:6
Acknowledgements
Financial support of this research from NIH, and travel
funds from NSF, are gratefully acknowledged.